Login / Signup
Na Li
ORCID
Publication Activity (10 Years)
Years Active: 2024-2024
Publications (10 Years): 3
Top Topics
Double Blind
Liver Injury
Placebo Controlled
Phase Iii
Top Venues
Clinical and translational science
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Na Li
,
Sepehr Shakib
,
Weilin Qian
,
Xiaoyan Yao
,
Puyuan Li
,
Tsz Keung Nip
,
Xiaoyan Bai
,
Kai Shen
Safety, pharmacokinetics, and pharmacodynamics of anti-IL-4Rα antibody SHR-1819 in healthy subjects: A randomized, controlled phase I study.
Clinical and translational science
17 (4) (2024)
Na Li
,
Sepehr Shakib
,
Weilin Qian
,
Xiaoyan Yao
,
Puyuan Li
,
Tsz Keung Nip
,
Xiaoyan Bai
,
Kai Shen
Safety, pharmacokinetics, and pharmacodynamics of anti-IL-4Rα antibody SHR-1819 in healthy subjects: A randomized, controlled phase I study.
Clinical and translational science
17 (4) (2024)
Na Li
,
Sepehr Shakib
,
Weilin Qian
,
Xiaoyan Yao
,
Puyuan Li
,
Tsz Keung Nip
,
Xiaoyan Bai
,
Kai Shen
Safety, pharmacokinetics, and pharmacodynamics of anti-IL-4Rα antibody SHR-1819 in healthy subjects: A randomized, controlled phase I study.
Clinical and translational science
17 (4) (2024)